An important observation in this regard was the apparent asso-
ciation of age with AMPK activity, peaking early on (~2 weeks) but
subsequently falling below TGWTlevels (after ~4 weeks). This,
coupled with the finding that reduction in AMPK activity extended
to involveγ1-containing AMPK complexes in older mice, high-
lighted the critical role of an extrinsic factor in modulating the
primary effect of mutations inγ2[ 34]. The inverse correlation
between myocardial glycogen levels (which steadily accumulate
with age) and AMPK activity in TG mice overexpressing mutant
PRKAG2provided a clear substrate for this (Fig.6)[ 35]. Substan-
tiating the primary impact ofγ2-mutations on the holoenzyme,200ABC1501001002 Days*
*2 DaysAge (weeks)^1WT TG WT TG WT TG WT TG WT TG24 820P-AMPK
Loading control1 Week1 Week2 Weeks2 Weeks
AgeAgeGlycogen Content(Fold Over Control)AMPK Activity (% of Control)
4 Weeks4 Weeks8 Weeks8 Weeks12 Weeks 20 WeeksWT
TG T400NWT
TG T400N20 Weeks8060
40
20
0500Fig. 6Inverse association between myocardial AMPK activity and glycogen content in TGT400Nmice. Temporal
change in cardiac AMPK activity (a), glycogen content (b), and panα-Thr172 phosphorylation (P-AMPK) (c)in
TGT400Nmice (Reproduced from ref.35 with permission from Elsevier)
598 Arash Yavari et al.